Clinical Trial of West-China Perioperative Transfusion Score (WCPTS)for Massive Hemorrhagic Surgery

Sponsor
Liu Jin (Other)
Overall Status
Unknown status
CT.gov ID
NCT01345643
Collaborator
(none)
120
1
2
46
2.6

Study Details

Study Description

Brief Summary

Guidelines for blood transfusion have been issued for years. According to these guidelines, red blood cells (RBCs) transfusion should be given when the hemoglobin level is less than 6g/dL or 7g/dL and is unnecessary when the level is more than 10g/dL. However, in all the guidelines, the determination of whether RBCs should be administered when the hemoglobin level is in the range of 7~10g/dL is based on the judgment from anesthesiologists or surgeons. Index of transfusion trigger for patients with hemoglobin level between 7/dL and 10g/dL is necessary and important in clinical practice. Based on the aim of blood transfusion that maintain the balance of oxygen supply and oxygen consumption, the investigators hypothesize that index of transfusion trigger for patients with hemoglobin level between 7/dL and 10g/dL could be calculated by their history about heart and blood pressure, and routine monitoring parameters including pulse oximetry, temperature, and the use of vasoactive medications. To verify this hypothesis, the investigators present West China Perioperative Transfusion Score (WCPTS) for the trigger of transfusion according to the patient's history and monitoring parameters, and the investigators design a randomized controlled clinical trial to test this score.

Condition or Disease Intervention/Treatment Phase
  • Other: Maintenance of hemoglobin level not less than 10g/dL
  • Other: Transfusion trigger based on WCPTS
Phase 3

Detailed Description

Surgery and trauma are the most common reasons for major blood loss, and blood transfusion provide guarantee for massive hemorrhagic surgery, especially orthopedic, cardiac, liver, and gynecologic procedures. On the other hand, blood transfusion is associated with many risks including hemolytic and nonhemolytic reactions, transfusion related acute lung injury, and others. Besides, blood is insufficient worldwide. How to eliminate allogeneic blood transfusion is an important part in clinical practice.

Guidelines for blood transfusion have been issued by many health institutions or organizations in different countries. According to these guidelines, red blood cells (RBCs) transfusion should be given when the hemoglobin level is less than 6g/dL or 7g/dL and is unnecessary when the level is more than 10g/dL. However, in all the guidelines, the determination of whether RBCs should be administered when the hemoglobin level is in the range of 7~10g/dL is based on the judgment from anesthesiologists or surgeons on the patient's condition including intravascular volume status, ongoing bleeding, any risk factors for vital organs ischemia or hypoxia, and so on. Index of transfusion trigger for patients with hemoglobin level between 7/dL and 10g/dL is necessary and important in clinical practice.

The aim of blood transfusion is to provide sufficient oxygen for the whole body, and to maintain the balance of oxygen supply and oxygen consumption. Factors associated with oxygen supply are hemoglobin level, cardiac output (CO), and oxygen saturation. Oxygen consumption is increased by the increase of metabolism, which could be reflected by increase of heart rate, blood pressure, and body temperature. If a patient's oxygen supply is decreased or oxygen consumption is increased, he will need a higher hemoglobin level to maintain the balance. Based on these findings, the investigators hypothesize that index of transfusion trigger for patients with hemoglobin level between 7/dL and 10g/dL could be calculated by their CO (reflectd by the use of adrenalin), and routine monitoring parameters including pulse oximetry and core temperature.

West China Perioperative Transfusion Score (WCPTS)

The initial score is 7.

If a patient's cardiac output (CO) is normal without contineous infusion of adrenalin, or his SpO2 is more than 95%, or his core temperature is less than 38℃, he doesn't have any bonus point factor, and his score is 7.

If a patient's CO is maintained in normal range by contineous adrenalin infusion with concentration of less than 0.05μg/kg.min, or his SpO2 is 8594%, or his core temperature is 3840℃, his score should be added 1 point for every item mentioned above.

If a patient's CO is only maintained by contineous adrenalin infusion with concentration of more than 0.05μg/kg.min, or his SpO2 is less than 84%, or his core temperature is above 40℃, his score should be added 2 points for every item mentioned above.

For example, if a patient's CO is normal, his SpO2 is more than 95%, and his core temperature is 39℃,his WCPTS should be calcultaed as 7 plus 1 (core temperature is 39℃), and his final score is 8.

Here's another example, if a patient's CO is normal, his core temperature is less than 38℃, but he has COPD and his SpO2 is less than 84%, his score could be calculated as 7 plus 2(SpO2 is less than 84%), and his final score is 9.

Value of SaO2 is evaluated 5min after endotracheal intubation with inhalation of compressive air.

The initial score is 7,and the patient's score is calculated by 7 plus the sum of every item.

Score 7:To maintain the patient's Hb level not less than 7g/dL

Score 8:To maintain the patient's Hb level not less than 8g/dL

Score 9:To maintain the patient's Hb level not less than 9g/dL

Score 10 or >10:To maintain the patient's Hb level not less than 10g/dL

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
A Randomized Controlled Clinical Trial of Transfusion Under the Guidance of West-China Perioperative Transfusion Score(WCPTS)for Massive Hemorrhagic Surgery
Study Start Date :
Feb 1, 2011
Anticipated Primary Completion Date :
Dec 1, 2013
Anticipated Study Completion Date :
Dec 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: Hemoglobin level based on WCPT Score

According to WCPTS, the patient's hemoglobin level will be maintained not less than 7,8,9,or 10g/dL. Determination of whether a patient need red blood cells transfusion is based on WCPT Score.

Other: Transfusion trigger based on WCPTS
Determination of whether a patient needs red blood cell transfusion or which hemoglobin level should be maintained is based on WCPTS

Active Comparator: Hemoglobin level 100g/L

The patient's hemoglobin level is maintained not less than 10g/dL perioperatively.

Other: Maintenance of hemoglobin level not less than 10g/dL
The patient's hemoglobin level is maintained not less than 10g/dL perioperatively.

Outcome Measures

Primary Outcome Measures

  1. Rate of red blood cells transfusion [one year postoperatively]

  2. Transfusion volume of red blood cells [One year postoperatively]

Secondary Outcome Measures

  1. Incidences of death and serious complications [one year postoperatively]

    Compare the incidences of death and complications, including postoperative bleeding, re-operation, cardiac events (cardiac ischemia, myocardial infarction,etc.), pulmonary events (infection, desaturation, etc.), transfusion related events (allergic reaction, hemolytic reaction, etc.), and others

  2. Healing of surgical incision [one year postoperatively]

  3. Time to get recovery of daily life and/or working [one year postoperatively]

  4. Length of ICU stay and hospitalization [one year postoperatively]

  5. Cost of hospitalization and transfusion [one year postoperatively]

Eligibility Criteria

Criteria

Ages Eligible for Study:
15 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • patients who sign the consent, with Glasgow Coma Scale (GCS) score of 15, undergoing surgery which blood loss could be more than 800ml or 20% of the patient's whole blood volume.
Exclusion Criteria:
  • Pregnancy

  • Psychopathy

  • Refuse to sign consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 West China Hosptial, Sichuan University Chengdu Sichuan China 610041

Sponsors and Collaborators

  • Liu Jin

Investigators

  • Study Director: Ren Liao, M.D., Department of Anesthesiology, West China Hospital, Sichuan University
  • Study Chair: Jin Liu, M.D., Department of Anesthesiology, West China Hospital, Sichuan University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Liu Jin, Chief of Department of Anesthesiology, West China Hospital
ClinicalTrials.gov Identifier:
NCT01345643
Other Study ID Numbers:
  • WCPTS110419
First Posted:
May 2, 2011
Last Update Posted:
Apr 8, 2013
Last Verified:
Apr 1, 2013
Keywords provided by Liu Jin, Chief of Department of Anesthesiology, West China Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 8, 2013